Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.62 |
| ▸ | CA1 | P00915 | 3/20 | 0.55 |
| ▸ | CA2 | P00918 | 1/20 | 0.55 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.47 |
| ▸ | USP2 | O75604 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | BIRC2 | Q13490 | 4/20 | 0.45 |
| ▸ | GPR84 | Q9NQS5 | 5/20 | 0.43 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.42 |
| ▸ | LCK | P06239 | 1/20 | 0.42 |
| ▸ | PPARD | Q03181 | 1/20 | 0.42 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.42 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8991586 | 0.98 | ZDHHC7 (0.66) | ZDHHC7CA1CA2ABCB1USP2 | |
| SCHEMBL8816706 | 0.98 | ZDHHC7 (0.66) | ZDHHC7CA1CA2ABCB1USP2 | |
| SCHEMBL7543085 | 0.98 | ZDHHC7 (0.66) | ZDHHC7CA1CA2ABCB1USP2 | |
| SCHEMBL486955 | 0.98 | ZDHHC7 (0.66) | ZDHHC7CA1CA2ABCB1USP2 | |
| SCHEMBL11160681 | 0.98 | ZDHHC7 (0.66) | ZDHHC7CA1CA2ABCB1USP2 | |
| SCHEMBL16832270 | 0.98 | ZDHHC7 (0.66) | ZDHHC7CA1CA2ABCB1USP2 | |
| SCHEMBL2944230 | 0.98 | ZDHHC7 (0.66) | ZDHHC7CA1CA2ABCB1USP2 | |
| SCHEMBL8584856 | 0.98 | ZDHHC7 (0.66) | ZDHHC7CA1CA2ABCB1USP2 | |
| SCHEMBL2293185 | 0.98 | ZDHHC7 (0.66) | ZDHHC7CA1CA2ABCB1USP2 | |
| SCHEMBL9781800 | 0.98 | ZDHHC7 (0.66) | ZDHHC7CA1CA2ABCB1USP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 73 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107793291-A | The method of hydrogenation catalyst and its preparation method and application and hydrogenation reaction | 中国石油化工股份有限公司 | 2018-03-13 | — | — | CN | claimed |
| CN-104558291-B | One kind is used for olefin polymerization catalysis preparation method | 中国石油化工股份有限公司 | 2017-05-31 | — | — | CN | claimed |
| CN-106608940-A | Preparation method for catalyst components used for olefin polymerization | 中国石油化工股份有限公司 | 2017-05-03 | — | — | CN | claimed |
| CN-106608939-A | Preparation method of catalyst component for olefin polymerization | 中国石油化工股份有限公司 | 2017-05-03 | — | — | CN | claimed |
| CN-104693205-B | Total synthesis method of amides alkaloid | 西安交通大学 | 2017-02-01 | — | — | CN | claimed |
| CN-104558293-A | Catalyst component for olefin polymerization and catalyst | CHINA PETROLEUM & CHEMICAL | 2015-04-29 | — | — | CN | claimed |
| CN-104558292-A | Preparation method of catalyst for olefin polymerization | CHINA PETROLEUM & CHEMICAL | 2015-04-29 | — | — | CN | claimed |
| CN-104558291-A | Preparation method of catalyst for olefin polymerization | CHINA PETROLEUM & CHEMICAL | 2015-04-29 | — | — | CN | claimed |
| CN-104558290-A | Components of catalyst for polymerization of olefins and catalyst | CHINA PETROLEUM & CHEMICAL | 2015-04-29 | — | — | CN | claimed |
| US-20250161291-A1 | SMALL MOLECULES FOR INHIBITING CHEMOKINE ACTIVITY AND/OR CANCER CELLS GROWTH | ALONBIO LTD. (IL) | 2025-05-22 | — | — | US | disclosed |
| US-12233057-B2 | Small molecules for inhibiting chemokine activity and/or cancer cells growth | ALONBIO LTD. (IL) | 2025-02-25 | — | — | US | disclosed |
| US-20230348362-A1 | LIPID COMPOUNDS AND LIPID NANOPARTICLE COMPOSITIONS | Suzhou Abogen Biosciences Co., Ltd. (CN) | 2023-11-02 | — | — | US | disclosed |
| US-20230233468-A1 | LIPID COMPOUNDS AND LIPID NANOPARTICLE COMPOSITIONS | Suzhou Abogen Biosciences Co., Ltd. (CN) | 2023-07-27 | — | — | US | disclosed |
| EP-3741432-B1 | QUINOLIN-2,4-ONE DERIVATIVES FOR INHIBITING CHEMOKINE ACTIVITY | ALONBIO LTD (IL) | 2023-05-10 | — | — | EP | disclosed |
| US-5344975-A | Process for production of lower alkanoic acids | WYCKOFF CHEMICAL COMPANY, INC. (US) | 1994-09-06 | — | — | US | disclosed |
| US-5338482-A | Liquid crystalline compounds, liquid crystal compositions containing the same and use thereof | DAISO CO., LTD. (JP) | 1994-08-16 | — | — | US | disclosed |
| EP-0355830-B1 | Liquid crystal composition and use thereof | DAISO CO LTD (JP) | 1994-04-27 | — | — | EP | disclosed |
| CN-1049501-A | AZABICYCLO QUINOLONE CARBOXYLIC ACIDS | PFIZER (US) | 1991-02-27 | — | — | CN | disclosed |
| EP-0410447-A2 | Liquid crystalline compounds, liquid crystal compositions containing the same and use thereof | DAISO CO., LTD. (JP) | 1991-01-30 | — | — | EP | disclosed |
| EP-0355830-A2 | Liquid crystal composition and use thereof | DAISO CO., LTD. (JP) | 1990-02-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12233057-B2 | Small molecules for inhibiting chemokine activity and/or cancer cells growth | CCL2, CXCR2, CCL5 | ZDHHC7 1375/4885CA1 3718/4885CA2 3938/4885 |
| US-20250161291-A1 | SMALL MOLECULES FOR INHIBITING CHEMOKINE ACTIVITY AND/OR CANCER CELLS GROWTH | CCL2, CXCR2, CCL5 | ZDHHC7 1375/4885CA1 3718/4885CA2 3938/4885 |
| US-20230233468-A1 | LIPID COMPOUNDS AND LIPID NANOPARTICLE COMPOSITIONS | CETP, NPC1, LCAT | ZDHHC7 220/4885CA1 3794/4885CA2 4200/4885 |
| US-20230348362-A1 | LIPID COMPOUNDS AND LIPID NANOPARTICLE COMPOSITIONS | CETP, NPC1, LCAT | ZDHHC7 220/4885CA1 3794/4885CA2 4200/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.